We show in a panel of ovarian tumours that while a high proportion of clear cell carcinomas overexpress eEF1A2, a far smaller proportion of serous, endometrioid and mucinous tumours have high levels of eEF1A2 expression. This evidence concerns the gene EEF1A2 and clear cell adenocarcinoma.